SWIFTWATER, Pa. – Sanofi Pasteur, the vaccine division of Sanofi has shipped the first of its nearly 70 million flu vaccine doses to health care providers for the upcoming flu season. This year’s supply uses both egg-based and recombinant technologies, and includes increased production of Flublok Quadrivalent vaccine and Fluzone High-Dose vaccine, as well as continued
HOUSTON — A recent Rice University study predicts the flu vaccine for fall 2018 — a new H3N2 formulation for the first time since 2015 — will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the vaccine given in 2016 and 2017 due to viral mutations related to vaccine
TORONTO — Health Canada has approved Sanofi Pasteur’s Fluzone High-Dose influenza vaccine developed for adults age 65 and older. A trivalent vaccine, Fluzone High-Dose contains four times the amount of hemagglutinin (HA) per strain versus a standard dose vaccine and is administered as a single, 0.5 ml intramuscular injection. The higher-dose flu shot, which already has
Late in 2014, we got news that the most prevalent circulating influenza virus strain this season, H3N2 (A/Switzerland/9715293/2013), was antigenically different from the H3N2 strain that was used to produce this year’s flu vaccine. Depending on the source from which one first heard this news, the sentiments ranged from the cynical — “the vaccine is
